Phagenesis secures £6m of funding
Biotechnology business Phagenesis today announced it has secured a £6m funding boost to accelerate its development plans.
Seventure Partners lead £3.5m second investment round in PhosphonicS, a cleantech company, alongside returning investors Regents Park Partners, a LBS venture capital fund, and private investors.